Orchid Pharma Limited — Board Meeting, 12-02-2025: Outcome of Board Meeting

Orchid Pharma Limited's Board of Directors has convened and approved the unaudited consolidated financial results for the quarter and nine months ended December 31, 2024. Key highlights include total outstanding loans of ₹73.44 crore, with no defaults reported. The Board also reviewed the statements of deviations for the quarter. The financial results will contribute to the company's strategic overview and possibly inform future operational decisions. Detailed results can be accessed on the company's website.